You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 11, November 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clomipramine Treatment of Obsessive-Compulsive Disorder

II. Biochemical Aspects

Peter Thorän, MD; Marie Åsberg, MD; Leif Bertilsson, PhD; Britt Mellstrüm, MPharm; Folke Sjüqvist, MD; Lil Träskman, MB

Arch Gen Psychiatry. 1980;37(11):1289-1294.


Abstract

• Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methixyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride. Patients who responded to clomipramine treatment had significantly higher CSF levels of 5-HIAA before treatment. The amelioration of obsessive-compulsive symptoms was positively correlated to the reduction of CSF concentrations of 5-HIAA during clomipramine treatment but negatively correlated to plasma concentrations of clomipramine. Reduction of CSF concentrations of 5-HIAA, which probably reflects drug action on central serotonin neurons, was maximal at a plasma clomipramine concentration of about 300 nmole/L. At higher levels, the reduction of CSF levels of 5-HIAA was smaller. The antiobsessive effect of clomipramine may be connected to its capacity to inhibit serotonin uptake.



Author Affiliations

From the Department of Psychiatry, Karolinska Hospital, Karolinska Institute, Stockholm (Drs Thorän, Åsberg, and Träskman); and the Department of Clinical Pharmacology, Huddinge Hospital, Karolinska Institute, Huddinge, Sweden (Drs Bertilsson, Mellstrüm, and Sjüqvist).


Footnotes

Accepted for publication March 20, 1980.

Reprint requests to Psychiatric Clinic, Karolinska Hospital, S-104 01 Stockholm 60, Sweden (Dr Åsberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder
Cath et al.
J Psychopharmacol 2001;15:111-119.
ABSTRACT  

The Neurobiology of Obsessive-Compulsive Disorder
Stein
Neuroscientist 1996;2:300-305.
ABSTRACT  

Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder: Comparison With Tourette's Syndrome and Healthy Controls
Leckman et al.
Arch Gen Psychiatry 1994;51:782-792.
ABSTRACT  

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine
Altemus et al.
Arch Gen Psychiatry 1994;51:794-803.
ABSTRACT  

Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors
Barr et al.
Arch Gen Psychiatry 1994;51:309-317.
ABSTRACT  

Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive Disorder
Altemus et al.
Arch Gen Psychiatry 1992;49:9-20.
ABSTRACT  

Serotonergic Function in Obsessive-Compulsive Disorder: Behavioral and Neuroendocrine Responses to Oral m-Chlorophenylpiperazine and Fenfluramine in Patients and Healthy Volunteers
Hollander et al.
Arch Gen Psychiatry 1992;49:21-28.
ABSTRACT  

Cerebrospinal Fluid Neurochemistry in Children and Adolescents With Obsessive-Compulsive Disorder
Swedo et al.
Arch Gen Psychiatry 1992;49:29-36.
ABSTRACT  

5-Hydroxytryptamine1A Receptor Responsivity in Obsessive-Compulsive Disorder: Comparison of Patients and Controls
Lesch et al.
Arch Gen Psychiatry 1991;48:540-547.
ABSTRACT  

Altered Serotonin Activity in Anorexia Nervosa After Long-term Weight Restoration: Does Elevated Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid Level Correlate With Rigid and Obsessive Behavior?
Kaye et al.
Arch Gen Psychiatry 1991;48:556-562.
ABSTRACT  

Prolactin and Cortisol Responses to MK-212, a Serotonin Agonist, in Obsessive-Compulsive Disorder
Bastani et al.
Arch Gen Psychiatry 1990;47:833-839.
ABSTRACT  

Local Cerebral Glucose Metabolic Rates in Obsessive-Compulsive Disorder: Patients Treated With Clomipramine
Benkelfat et al.
Arch Gen Psychiatry 1990;47:840-848.
ABSTRACT  

Cerebrospinal Fluid Monoamine Metabolites, Aggression, and Impulsivity in Disruptive Behavior Disorders of Children and Adolescents
Kruesi et al.
Arch Gen Psychiatry 1990;47:419-426.
ABSTRACT  

Signs of Central Nervous System Dysfunction in Obsessive-Compulsive Disorder
Hollander et al.
Arch Gen Psychiatry 1990;47:27-32.
ABSTRACT  

Clomipramine in Obsessive-Compulsive Disorder: Further Evidence for a Serotonergic Mechanism of Action
Benkelfat et al.
Arch Gen Psychiatry 1989;46:23-28.
ABSTRACT  

Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman et al.
Arch Gen Psychiatry 1989;46:36-44.
ABSTRACT  

Serotonergic Responsivity in Obsessive-Compulsive Disorder: Effects of Chronic Clomipramine Treatment
Zohar et al.
Arch Gen Psychiatry 1988;45:167-172.
ABSTRACT  

Serotonin Function in Obsessive-Compulsive Disorder: A Comparison of the Effects of Tryptophan and m-Chlorophenylpiperazine in Patients and Healthy Subjects
Charney et al.
Arch Gen Psychiatry 1988;45:177-185.
ABSTRACT  

Monoamine Neurotransmitter Interactions and the Prediction of Antidepressant Response
Hsiao et al.
Arch Gen Psychiatry 1987;44:1078-1083.
ABSTRACT  

Local Cerebral Glucose Metabolic Rates in Obsessive-Compulsive Disorder: A Comparison With Rates in Unipolar Depression and in Normal Controls
Baxter et al.
Arch Gen Psychiatry 1987;44:211-218.
ABSTRACT  

Biochemical Changes During Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder
Flament et al.
Arch Gen Psychiatry 1987;44:219-225.
ABSTRACT  

Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament et al.
Arch Gen Psychiatry 1985;42:977-983.
ABSTRACT  

Obsessive-Compulsive Disorder: A Double-blind Trial of Clomipramine and Clorgyline
Insel et al.
Arch Gen Psychiatry 1983;40:605-612.
ABSTRACT  

Monoamine Metabolites in CSF and Suicidal Behavior
Traskman et al.
Arch Gen Psychiatry 1981;38:631-636.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.